Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
7
Number of overlapping holdings
13.5%
% of BBP's 55 holdings also in IBRN
18.4%
% of IBRN's 54 holdings also in BBP
Overlap by Weight
Sector Drift (BBP minus IBRN)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBP |
Weight in IBRN |
Overlap | |
|---|---|---|---|---|
 |
SAREPTA THERAPEUTICS INC | 2.4% | 4.8% | 2.4% |
|
PTC THERAPEUTICS INC | 2.1% | 4.7% | 2.1% |
|
INTRA-CELLULAR THERAPIES INC | 2.0% | 4.3% | 2.0% |
|
NEUROCRINE BIOSCIENCES INC | 1.9% | 4.9% | 1.9% |
|
BIOGEN IDEC INC | 1.5% | 4.7% | 1.5% |
Position Highlights (Non-Overlapping Exposures)
BBP Overweight Relative to IBRN
|
TARSUS PHARMACEUTICALS, INC. | 3.5% |
|
LEXICON PHARMACEUTICALS, INC. | 3.4% |
|
SPRINGWORKS THERAPEUTICS, INC. | 2.6% |
|
AGIOS PHARMACEUTICALS INC | 2.5% |
|
ADMA BIOLOGICS, INC. | 2.5% |
|
CRISPR THERAPEUTICS AG | 2.4% |
|
KINIKSA PHARMACEUTICALS LTD. CLASS A | 2.3% |
|
ASCENDIS PHARMA A/S | 2.3% |
|
APELLIS PHARMACEUTICALS, INC. | 2.2% |
|
ULTRAGENYX PHARMACEUTICAL IN | 2.1% |
BBP Underweight Relative to IBRN
|
CEREVEL THERAPEUTICS HOLDINGS INC | -4.8% |
|
AXONICS MODULATION TECHNOLOGIES, INC | -4.7% |
 |
ARGENX SE ADR | -4.5% |
 |
SK BIOPHARMACEUTICALS CO., LTD. | -3.8% |
 |
ALKERMES PLC | -3.7% |
|
INTEGRA LIFESCIENCES HOLDING | -3.4% |
|
CATALYST PHARMACEUTICAL PART | -3.3% |
|
BIOGEN IDEC INC | -3.2% |
|
SUPERNUS PHARMACEUTICALS INC | -3.1% |
|
NEUROCRINE BIOSCIENCES INC | -2.9% |